Facebook
Twitter
Telegram
Fehler meldenAquestive Therapeutics Finanzdaten 2011-2024 | AQST
Jahresabschluß Aquestive Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
257 M | 40.9 M | 148 M | 179 M | 102 M | 148 M | - | - | - | - | - | - | - |
Anteile |
61.3 M | 48.7 M | 38.1 M | 33.8 M | 25.4 M | 20.7 M | - | - | - | - | - | - | - |
Kurshistorie |
4.19 | 0.84 | 3.89 | 5.35 | 5.82 | 6.3 | - | - | - | - | - | - | - |
Nettogewinn |
-7.87 M | -54.4 M | -70.5 M | -55.8 M | -66.2 M | -61.4 M | -8.94 M | -9.6 M | - | - | - | - | - |
Umsatz |
50.6 M | 47.7 M | 50.8 M | 45.8 M | 52.6 M | 67.4 M | 66.9 M | 51.8 M | - | - | - | - | - |
Umsatzkosten |
20.8 M | 19.4 M | - | 13 M | 20.4 M | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | 32.9 M | 32.2 M | 46.4 M | 47.1 M | 35.4 M | - | - | - | - | - |
Betriebsergebnis |
-15.1 M | -42.1 M | -34.7 M | -42.9 M | -52.7 M | -48.9 M | -113 K | - | - | - | - | - | - |
Zinsaufwendungen |
6.34 M | 6.55 M | 10 M | 11.1 M | 9.32 M | 7.71 M | 7.71 M | - | - | - | - | - | - |
EBITDA |
-13.8 M | -39.7 M | -31.7 M | -39.4 M | -49.8 M | -45.7 M | 3.69 M | 3.04 M | - | - | - | - | - |
Betriebsaufwand |
- | - | 85.5 M | 75.8 M | 84.9 M | 95.4 M | 47.2 M | 36.3 M | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
31.8 M | 52.9 M | 53.5 M | 55.9 M | 64.3 M | 72.3 M | 25.1 M | 20.8 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Aquestive Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
73.6 M | 68.5 M | 64.7 M | 57.4 M | 55.6 M | 54.8 M | 53.4 M | 45.5 M | 41.5 M | 41.2 M | 39.2 M | 37.1 M | 35.6 M | 34.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 25 M | 25 M | 25 M | 25 M | 23.6 M | 19.2 M | 15.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-12.8 M | - | -2.04 M | -5.79 M | 8.07 M | - | -12.5 M | -16.3 M | -13.2 M | - | -14.6 M | -12.4 M | -14.7 M | -20.4 M | -16.6 M | -2.33 M | -16.5 M | -12.6 M | -18.4 M | -20.5 M | -14.7 M | -13.9 M | -15 M | -36.5 M | 4.1 M | -10 M | 8.45 M | -5.9 M | -1.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatz |
12.1 M | - | 13 M | 13.2 M | 11.1 M | - | 11.5 M | 13.3 M | 12.3 M | - | 13.3 M | 15.3 M | 11.1 M | 7.15 M | 8.26 M | 21.7 M | 8.76 M | 16.4 M | 12.4 M | 11.1 M | 12.6 M | 16.8 M | 13.3 M | 13.9 M | 23.4 M | 12.2 M | 27.1 M | 11.1 M | 16.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
4.39 M | - | 4.8 M | 6.62 M | 4.74 M | - | 4.62 M | 5.24 M | 4.21 M | - | 4.4 M | 4.47 M | 2.76 M | 2.79 M | 2.98 M | 3.54 M | 3.66 M | 6.79 M | 4.64 M | 5.42 M | 3.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-8.96 M | - | -2.38 M | -4.21 M | -4.6 M | - | -8.85 M | -12.8 M | -9.74 M | - | -7.97 M | -6.52 M | -8.52 M | - | -13.8 M | 395 K | -13.9 M | - | -11 M | -18.7 M | -13.1 M | - | -9.2 M | -32.7 M | 5.3 M | - | 10.4 M | -4.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
2.78 M | - | 1.26 M | 1.37 M | 1.44 M | - | 1.65 M | 1.64 M | 1.62 M | - | 2.79 M | 2.76 M | 2.76 M | - | 2.78 M | 2.75 M | 2.77 M | - | 2.65 M | 1.94 M | 1.93 M | - | 1.93 M | 1.93 M | 1.93 M | - | 1.97 M | 1.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-8.75 M | - | -2.16 M | -3.96 M | -4.28 M | - | -8.3 M | -12.1 M | -9.01 M | - | -5.74 M | -5.79 M | -7.77 M | - | -11.4 M | 2.08 M | -13 M | - | -8.71 M | -17.1 M | -12.3 M | - | -8.47 M | -31.9 M | 6.24 M | - | 11.4 M | -3.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.6 M | 26.3 M | 23.4 M | 29.8 M | 25.7 M | 29.2 M | 22.5 M | 46.6 M | 18.1 M | 19.4 M | 16.7 M | 15.2 M | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
10.7 M | - | 7.38 M | 7.36 M | 7.46 M | - | 12.5 M | 15.6 M | 13 M | - | 12.1 M | 13.1 M | 13.2 M | - | 11.8 M | 13.9 M | 14.6 M | - | 13.7 M | 16.2 M | 17.9 M | - | 12.3 M | 33.7 M | 7.57 M | - | 6.16 M | 5.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung